This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,330.94 firm-fixed-price delivery order is for the supply of PEGASYS 180 MCG/ML VIALML, a specialty pharmaceutical product, with a period of performance through November 19, 2024.
The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
The contract award did not include any set-aside designations, indicating open competition. Amerisourcebergen is a for-profit organization registered in the System for Award Management (SAM.gov) and has a significant presence as a vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.
Generated 2/17/25, 9:41 PM